Anuh Pharma Reports Strong H1 FY27 Profitability With Significant Margin Expansion
Anuh Pharma Ltd · Investor Presentation · 06 Nov 2026, 8:28 pm
Anuh Pharma Reports Strong H1 FY27 Profitability With Significant Margin Expansion In H1 FY27, Anuh Pharma posted operating revenue of Rs 379.05 Cr, up 1.80% YoY, prioritizing higher-value products over volume. EBITDA surged 39.11% YoY to Rs 36.92 Cr as EBITDA margin expanded 261 bps to 9.74%. PAT jumped 42.25% YoY to Rs 22.64 Cr, while production grew 15.31% YoY to 987 MT. The company remains net debt-free with ROCE reaching 16.52%. Following the commissioning of its Tarapur Unit F-10, raising total capacity to 2,975 MTPA, management targets 15–20% annual growth driven by export recovery and pipeline commercialization.
Original exchange filing (PDF)
More announcements from Anuh Pharma Ltd
- Capacity Addition by inauguration of the F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. · 16 Nov 2026
- This is to inform that the Company has inaugurated its new manufacturing facility situated at F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. · 16 Nov 2026
- Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category". · 30 Oct 2026
- Unaudited Financial Results for the Quarter and half year ended 30th September, 2026. · 30 Oct 2026
- Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'. · 30 Oct 2026
- To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September, 2026 and Request received for withdrawal .... · 30 Oct 2026
- Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- ANUH PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 30 Oct 2026
